Skip to main content

Advertisement

SpringerLink
Log in

The Long Elusive IgM Fc Receptor, FcμR

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

IgM exists as both a monomer on the surface of B cells and a pentamer secreted by plasma cells. Both pre-immune “natural” and antigen-induced “immune” IgM antibodies are important for protective immunity and for immune regulation of autoimmune processes by recognizing pathogens and self-antigens. Effector proteins interacting with the Fc portion of IgM, such as complement and complement receptors, have thus far been proposed but fail to fully account for the IgM-mediated protection and regulation. A major reason for this deficit in our understanding of IgM function seems to be lack of data on a long elusive Fc receptor for IgM (FcμR). We have recently identified a bona fide FcμR in both humans and mice. In this article we briefly review what we have learned so far about FcμR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol. 1991;9:457–92.

    Article  CAS  PubMed  Google Scholar 

  2. Daëron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203–34.

    Article  PubMed  Google Scholar 

  3. Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu Rev Immunol. 2003;21:177–204.

    Article  CAS  PubMed  Google Scholar 

  4. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcγRIV: a novel FcR with distinct IgG subclass specificity. Immunity. 2005;23(1):41–51.

    Article  CAS  PubMed  Google Scholar 

  5. Kubagawa H, Oka S, Kubagawa Y, Torii I, Takayama E, Kang DW, et al. Identity of the elusive IgM Fc receptor (FcμR) in humans. J Exp Med. 2009;206(12):2779–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Honjo K, Kubagawa Y, Jones DM, Dizon B, Zhu Z, Ohno H, et al. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR). Proc Natl Acad Sci U S A. 2012;109(39):15882–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Moretta L, Webb SR, Grossi CE, Lydyard PM, Cooper MD. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM (Tμ) or IgG (Tγ). J Exp Med. 1977;146(1):184–200.

    Article  CAS  PubMed  Google Scholar 

  8. Reinherz EL, Moretta L, Roper M, Breard JM, Mingari MC, Cooper MD, et al. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies: a comparison. J Exp Med. 1980;151(4):969–74.

    Article  CAS  PubMed  Google Scholar 

  9. Sanders SK, Kubagawa H, Suzuki T, Butler JL, Cooper MD. IgM binding protein expressed by activated B cells. J Immunol. 1987;139(1):188–93.

    CAS  PubMed  Google Scholar 

  10. Ohno T, Kubagawa H, Sanders SK, Cooper MD. Biochemical nature of an Fcμ receptor on human B-lineage cells. J Exp Med. 1990;172(4):1165–75.

    Article  CAS  PubMed  Google Scholar 

  11. Nakamura T, Kubagawa H, Ohno T, Cooper MD. Characterization of an IgM Fc-binding receptor on human T cells. J Immunol. 1993;151(12):6933–41.

    CAS  PubMed  Google Scholar 

  12. Vire B, David A, Wiestner A. TOSO, the Fcμ receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J Immunol. 2011;187(8):4040–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Pricop L, Rabinowich H, Morel PA, Sulica A, Whiteside TL, Herberman RB. Characterization of the Fcμ receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects. J Immunol. 1993;151(6):3018–29.

    CAS  PubMed  Google Scholar 

  14. Nguyen XH, Lang PA, Lang KS, Adam D, Fattakhova G, Foger N, et al. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood. 2011;118(3):598–608.

    Article  CAS  PubMed  Google Scholar 

  15. Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ, et al. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 1998;8(4):461–71.

    Article  CAS  PubMed  Google Scholar 

  16. Honjo K, Kubagawa Y, Kubagawa H. Is Toso an antiapoptotic protein or an Fc receptor for IgM? Blood. 2012;119(7):1789–90.

    Article  CAS  PubMed  Google Scholar 

  17. Murakami Y, Narayanan S, Su S, Childs R, Krzewski K, Borrego F, et al. Toso, a functional IgM receptor, is regulated by IL-2 in T and NK cells. J Immunol. 2012;189(2):587–97.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Hamburger AE, West Jr AP, Bjorkman PJ. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure. 2004;12(11):1925–35.

    Article  CAS  PubMed  Google Scholar 

  19. Hoover RG, Dieckgraefe BK, Lynch RG. T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA. J Immunol. 1981;127(4):1560–3.

    CAS  PubMed  Google Scholar 

  20. Reljic R. In search of the elusive mouse macrophage Fcα receptor. Immunol Lett. 2006;107(1):80–1.

    Article  PubMed  Google Scholar 

  21. Maruoka T, Nagata T, Kasahara M. Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics. 2004;55(10):712–6.

    Article  CAS  PubMed  Google Scholar 

  22. Adachi T, Harumiya S, Takematsu H, Kozutsumi Y, Wabl M, Fujimoto M, et al. CD22 serves as a receptor for soluble IgM. Eur J Immunol. 2012;42(1):241–7.

    Article  CAS  PubMed  Google Scholar 

  23. Poe JC, Tedder TF. CD22 and Siglec-G in B cell function and tolerance. Trends Immunol. 2012;33(8):413–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. McEwan WA, Tam JC, Watkinson RE, Bidgood SR, Mallery DL, James LC. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol. 2013;14(4):327–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Randow F, MacMicking JD, James LC. Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science. 2013;340(6133):701–6.

    Article  CAS  PubMed  Google Scholar 

  26. Tissot JD, Sanchez JC, Vuadens F, Scherl A, Schifferli JA, Hochstrasser DF, et al. IgM are associated to Sp alpha (CD5 antigen-like). Electrophoresis. 2002;23(7–8):1203–6.

    Article  CAS  PubMed  Google Scholar 

  27. Martinez VG, Moestrup SK, Holmskov U, Mollenhauer J, Lozano F. The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev. 2011;63(4):967–1000.

    Article  CAS  PubMed  Google Scholar 

  28. Miyazaki T, Kurokawa J, Arai S. AIMing at metabolic syndrome. Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM). Circ J. 2011;75(11):2522–31.

    Article  CAS  PubMed  Google Scholar 

  29. Arai S, Maehara N, Iwamura Y, Honda S, Nakashima K, Kai T, et al. Obesity-associated autoantibody production requires AIM to retain the immunoglobulin M immune complex on follicular dendritic cells. Cell Rep. 2013;3(4):1187–98.

    Article  CAS  PubMed  Google Scholar 

  30. Reth M. Antigen receptor tail clue. Nature. 1989;338(6214):383–4.

    Article  CAS  PubMed  Google Scholar 

  31. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 1994;76(2):263–74.

    Article  CAS  PubMed  Google Scholar 

  32. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol. 1995;155(7):3281–5.

    CAS  PubMed  Google Scholar 

  33. Vely F, Vivier E. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol. 1997;159(5):2075–7.

    CAS  PubMed  Google Scholar 

  34. Cambier JC. Inhibitory receptors abound? Proc Natl Acad Sci U S A. 1997;94(12):5993–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol. 2003;4(1):19–24.

    Article  CAS  PubMed  Google Scholar 

  36. Engels N, Konig LM, Heemann C, Lutz J, Tsubata T, Griep S, et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol. 2009;10(9):1018–25.

    Article  CAS  PubMed  Google Scholar 

  37. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad Jr J, Miljkovic V, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A. 2003;100(5):2639–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Riou C, Yassine-Diab B, van Grevenynghe J, Somogyi R, Greller LD, Gagnon D, et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med. 2007;204(1):79–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013):44–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Shibuya A, Sakamoto N, Shimizu Y, Shibuya K, Osawa M, Hiroyama T, et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol. 2000;1(5):441–6.

    Article  CAS  PubMed  Google Scholar 

  41. Kikuno K, Kang DW, Tahara K, Torii I, Kubagawa HM, Ho KJ, et al. Unusual biochemical features and follicular dendritic cell expression of human Fcα/μ receptor. Eur J Immunol. 2007;37(12):3540–50.

    Article  CAS  PubMed  Google Scholar 

  42. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O’Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med. 2008;205(8):1797–805.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Pichler WJ, Knapp W. Receptors for IgM-coated erythrocytes on chronic lymphatic leukemia cells. J Immunol. 1977;118(3):1010–5.

    CAS  PubMed  Google Scholar 

  44. Ferrarini M, Hoffman T, Fu SM, Winchester R, Kunkel HG. Receptors for IgM on certain human B lymphocytes. J Immunol. 1977;119(4):1525–9.

    CAS  PubMed  Google Scholar 

  45. Burns GF, Cawley JC, Barker CR. Characterization of the receptor for IgM present on human B lymphocytes. Immunology. 1979;36(3):569–77.

    CAS  PubMed Central  PubMed  Google Scholar 

  46. Rudders RA, Andersen J, Howard JP, Fried R. The binding of IgM to B lymphocytes. I. Studies of the binding of aggregated IgM to normal and leukemic human B lymphocytes. Clin Immunol Immunopathol. 1980;15(4):673–86.

    Article  CAS  PubMed  Google Scholar 

  47. Platsoucas CD, Kempin S, Karanas A, Clarkson B, Good RA, Gupta S. Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol. 1980;40(2):256–63.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Proto-Siqueira R, Panepucci RA, Careta FP, Lee A, Clear A, Morris K, et al. SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood. 2008;112(2):394–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Pallasch CP, Schulz A, Kutsch N, Schwamb J, Hagist S, Kashkar H, et al. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease. Blood. 2008;112(10):4213–9.

    Article  CAS  PubMed  Google Scholar 

  50. Pallasch CP, Wendtner CM. Overexpression of the Fas-inhibitory molecule TOSO: a novel antiapoptotic factor in chronic lymphocytic leukemia. Leuk Lymphoma. 2009;50(3):498–501.

    Article  CAS  PubMed  Google Scholar 

  51. Li FJ, Kubagawa Y, McCollum MK, Wilson L, Motohashi T, Bertoli LF, et al. Enhanced levels of both membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia. Blood. 2011;118(18):4902–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Duhren-von MM, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature. 2012;489(7415):309–12.

    Article  Google Scholar 

  53. Stevenson FK, Hamblin TJ, Stevenson GT, Tutt AL. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes. J Exp Med. 1980;152(6):1484–96.

    Article  CAS  PubMed  Google Scholar 

  54. Qian GX, Fu SM, Solanki DL, Rai KR. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM. J Immunol. 1984;133(6):3396–400.

    CAS  PubMed  Google Scholar 

  55. Bertoli LF, Kubagawa H, Borzillo GV, Mayumi M, Prchal JT, Kearney JF, et al. Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and a large cell lymphoma (Richter’s syndrome). Blood. 1987;70(1):45–50.

    CAS  PubMed  Google Scholar 

  56. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352(8):804–15.

    Article  CAS  PubMed  Google Scholar 

  57. Lang KS, Lang PA, Meryk A, Pandyra AA, Boucher LM, Pozdeev VI, et al. Involvement of Toso in activation of monocytes, macrophages, and granulocytes. Proc Natl Acad Sci U S A. 2013;110(7):2593–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Honjo K, Kubagawa Y, Kubagawa H. Is Toso/IgM Fc receptor (FcμR) expressed by innate immune cells? Proc Natl Acad Sci U S A. 2013;110(28):E2540–1.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Ouchida R, Mori H, Hase K, Takatsu H, Kurosaki T, Tokuhisa T, et al. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc Natl Acad Sci U S A. 2012;17:E2699–706.

    Article  Google Scholar 

  60. Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F, et al. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J Immunol. 2013;190(3):987–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Ehrenstein MR, Notley CA. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol. 2010;10(11):778–86.

    Article  CAS  PubMed  Google Scholar 

  62. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol. 1998;160(10):4776–87.

    CAS  PubMed  Google Scholar 

  63. Ehrenstein MR, O’Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A. 1998;95(17):10089–93.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  64. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med. 1998;188(12):2381–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med. 2000;192(2):271–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol. 2010;184(10):5755–67.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, Chen J. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A. 2000;97(3):1184–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Ehrenstein MR, Cook HT, Neuberger MS. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med. 2000;191(7):1253–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The studies described in this article are accomplished based on the earlier studies on FcμR by Dr. Tatsuharu Ohno and Dr. Tetsuya Nakamura in the laboratory of Dr. Max Cooper and the authors wish to express our gratitude to them for their solid work and to Dr. Max Cooper for his great mentorship. This work was supported in part by National Institute of Health, National Institute of Allergy and Infectious Diseases Grants AI52243, R56AI82249, and R21AI94624 (to HK). Regretfully, Dr. Toshio Miyawaki, Professor Emeritus of Toyama University, was diseased on February 26, 2014, and we would like to offer our deepest sympathy.

Conflict of interest

The authors declare no conflicting financial interests.

Author information

Authors and Affiliations

  1. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35209, USA

    Hiromi Kubagawa, Satoshi Oka, Yoshiki Kubagawa, Ikuko Torii, Eiji Takayama, Dong-Won Kang, Dewitt Jones, Sheila K. Sanders & Kazuhito Honjo

  2. Hematology and Oncology, Shiga Medical Center for Adults, Shiga, 524-8524, Japan

    Satoshi Oka

  3. Department of Pathology, Hyogo College of Medicine, Hyogo, 663-8501, Japan

    Ikuko Torii

  4. Department of Oral Biochemistry, Asahi University School of Dentistry, Gifu, 501-0296, Japan

    Eiji Takayama

  5. Department of Biomedical Engineering, Emory University, Atlanta, GA, 30332, USA

    Dong-Won Kang

  6. Department of Pediatrics, Toyama University, Toyama, 930-0194, Japan

    Naonori Nishida & Toshio Miyawaki

  7. Brookwood Medical Center, Birmingham, AL, 35209, USA

    Luigi F. Bertoli

Authors
  1. Hiromi Kubagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoshi Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiki Kubagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ikuko Torii
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eiji Takayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong-Won Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dewitt Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Naonori Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Toshio Miyawaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Luigi F. Bertoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Sheila K. Sanders
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kazuhito Honjo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiromi Kubagawa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kubagawa, H., Oka, S., Kubagawa, Y. et al. The Long Elusive IgM Fc Receptor, FcμR. J Clin Immunol 34 (Suppl 1), 35–45 (2014). https://doi.org/10.1007/s10875-014-0022-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-014-0022-7

Keywords

Search

Navigation